Coronavirus Global News Tracker: Live Updates

Here’s what you need to know: ImageWorkers disinfect a street in downtown Cairo last week.Credit…Fadl AbuZaid/Picture Alliance, via Getty Images The virus surges in regions where populist leaders thought they’d been spared. For months, one enduring mystery of the coronavirus was why some countries with rickety health systems and crowded slums had managed to avoid…

NMDA receptors may link psychosis and sleep deficits

Sofya Kulikova, a researcher at HSE University in Perm, is part of an international research team that has discovered potential mechanisms that explain the sleep spindle deficit in electroencephalograms (EEG) of people with schizophrenia. The article was published in the Schizophrenia Research on June 5. https://www.sciencedirect.com/science/article/abs/pii/S092099642030236X?via%3Dihub&fbclid=IwAR2VFGlKtqeYMsdtFidYS5yNpbarRGRA8Wts6TkIOCiWyDfkBot7z_yJs7w Individuals with schizophrenia are often characterized by a deficit…

Analysis of Seattle EMS and hospital data indicates low COVID infection risk from bystander CPR

DALLAS, June 5, 2020 — Analysis of Seattle emergency medical services (EMS) and hospital data from January 1 to April 15, 2020, indicates bystander CPR is a lifesaving endeavor whose benefits outweigh the risks of COVID-19 infection, according to a new article published yesterday in the American Heart Association’s flagship journal Circulation. Resuscitation of patients…

Narayanan studying application of brilacidin for treatment of coronavirus infections

Narayanan Studying Application Of Brilacidin For Treatment Of Coronavirus Infections Aarthi Narayanan, Assistant Professor, National Center for Biodefense and Infectious Diseases, received $35,000 from Innovation Pharmaceuticals, Inc., for a project in which she is examining the use of Brilacidin for the treatment of coronavirus infections. Brilacidin is an investigational new drug. It is a polymer-based…